Skip to main content

NPF Endorsed Features

Joshua A. Grosshandler, MD, FAAD
Questions regarding biologic continuation vs cessation come up often when patients with psoriasis or psoriatic arthritis need surgery, but the answers still need an in-depth discussion with the surgeon and patient.
Kristi Hawley, DO
Psoriasis has a known association with inflammatory bowel disease, including Crohn disease and ulcerative colitis. Dermatologists should keep the association in mind when treating their patients with psoriasis.
Melissa Weiss, Associate Editor, and Lauren Mateja, Managing Editor
Dr Takeshita identifies and discusses various disparities in care for patients of racial and ethnic minority groups who have psoriasis.
Robert S. Rahimi, MD, MSCR
While several comorbidities have been associated with psoriasis, dermatologists should know the risks and complications of hepatic disease for this patient group.
Lauren Mateja, Managing Editor
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Joel M. Gelfand, MD, MSCE
Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.
Lauren Mateja, Managing Editor
Kristian Reich, MD, PhD, discussed a therapeutic breakthrough with bimekizumab, a novel biologic in development that inhibits IL-17F in addition to IL-17A.
Sonya Zarkhin, DO, Nichelle Madden, DO, Kristi Hawley, DO, Sean Stephenson, DO
Linear psoriasis, a rare variant of psoriasis, is not well understood, but its course of treatment is similar to other psoriatic presentations. The authors report a successfully treated case of linear psoriasis in a 19-year-old female patient.
Lauren Mateja, Managing Editor
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass on to their patients.
Lauren Mateja, Managing Editor
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
Back to Top